A detailed history of Cottage Street Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Cottage Street Advisors LLC holds 486 shares of LLY stock, worth $444,481. This represents 0.23% of its overall portfolio holdings.

Number of Shares
486
Previous 487 0.21%
Holding current value
$444,481
Previous $283 Million 33.61%
% of portfolio
0.23%
Previous 0.19%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

SELL
$592.2 - $792.28 $592 - $792
-1 Reduced 0.21%
486 $378 Million
Q4 2023

Jan 18, 2024

SELL
$525.19 - $619.13 $7,352 - $8,667
-14 Reduced 2.79%
487 $283 Million
Q3 2023

Nov 06, 2023

BUY
$434.7 - $599.3 $6,955 - $9,588
16 Added 3.3%
501 $269 Million
Q2 2023

Jul 24, 2023

BUY
$350.74 - $468.98 $170,108 - $227,455
485 New
485 $227 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $869B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Cottage Street Advisors LLC Portfolio

Follow Cottage Street Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cottage Street Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cottage Street Advisors LLC with notifications on news.